Am J Transplant, Volume 18, Suppl 3 Archives - Page 13 of 211 - ATC Abstracts

2018 American Transplant Congress
Many Highly Sensitized Candidates Still Waiting for Transplant Despite the Kidney Allocation System Change: Making the Case for Incompatible Transplantation
C. Schinstock, B. Smith, A. Bentall, M. Stegall.
Von Liebig Center for Transplantation and Clinical Regenerative Medicine, Mayo Clinic, Rochester, MN.
Introduction: The rate of kidney transplantation in highly sensitized individuals has increased since the kidney allocation system (KAS) change, but it remains unclear who has…
2018 American Transplant Congress
ABO Incompatible Deceased Donor Kidney Transplantation – Time to Remove the Barrier
J. Melancon,¹ M. Nayebpour,² K. Mahendran,¹ H. Spivak,¹ N. Koizumi.²
¹Transplant Institute and Division of Transplant Surgery, The George Washington University Hospital, Washington, DC; ²George Mason University, Washington, DC.
Objective: To propose a new allocation system for deceased donor kidney transplants that would decrease cold ischemia time, increase HLA matching, decrease kidney discard rates…
2018 American Transplant Congress
Safety and Efficacy of Real-World Use of Everolimus for Kidney Transplant Patients: Post-Marketing Surveillance in Japan
H. Harada,¹ Y. Watarai,² J. Uchida,³ O. Kamisawa.⁴
¹Sapporo City General Hospital, Sapporo, Japan; ²Nagoya Daini Red Cross Hospital, Nagaya, Japan; ³Osaka City University, Osaka, Japan; ⁴Novartis Pharma K.K., Tokyo, Japan.
Background and purpose: After the approval of everolimus (EVR) in 2011 in Japan to prevent organ rejection in kidney transplant (KTx) patients, no data on…
2018 American Transplant Congress
The Impact of Marginal Factors on Postoperative Kidney Function of Complex Living Donors for Kidney Transplantation
T. Hiramitsu, K. Futamura, M. Okada, M. Tsujita, T. Ichimori, N. Goto, S. Narumi, Y. Watarai.
Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan.
BackgroundRecently, complex living donors with marginal factors including hypertension, dyslipidemia, glucose intolerance, and obesity are increasing. Postoperative kidney function of living donors for kidney transplantation…
2018 American Transplant Congress
Impact of Overseas Organ Transplantation on Outcome of Kidney Transplant Patients
M. Mammadli,¹ H. Ismayilov,¹ A. Asgarli,² F. Babayev,⁴ I. Hemidov,⁴ R. Shahbazov.³
¹Nephrology, Medservice Medical Center, Baku, Azerbaijan; ²School of Medicine, Acibadem University, Istanbul, Turkey; ³Surgery, University of Virginia Healthsystem, Charlottesville, VA; ⁴Nephrology and Hemodialysis, Republic Urology Hospital, Baku, Azerbaijan.
Background.Kidney transplantation is an effective treatment option for patients with end stage renal disease (ESRD). Although there is a trend to decrease in overseas transplantation…
2018 American Transplant Congress
Impact of Psychosocial Variables on Renal Allograft Rejection Risk: A Multivariate Analysis
D. Chernobylsky, K. Carsky, C. McDermott, P. Ferrin, R. Fernandez, I. Gaines, M. Killackey, R. Zhang, A. Paramesh, J. Buell.
Transplant Surgery, Tulane University School of Medicine, New Orleans, LA.
Transplant-specific risk factors for rejection are well documented, yet psychosocial variable correlation with rejection risk is not; this analysis seeks to determine the relationship between…
2018 American Transplant Congress
Associations among Physical Fitness/function, Pain and Depression in Kidney Transplant Patients
A. Kastelz,^1,2 I. Tzvetanov,¹ B. Fernhall,² A. Shetty,³ L. Gallon,³ G. Hachaj,⁴ E. Benedetti.¹
¹Surgery, University of Illinois, Chicago, IL; ²Integrative Physiology Lab, University of Illinois, Chicago, IL; ³Internal Medicine Nephrology, Northwestern Medical Group, Chicago, IL; ⁴GH FitLab, Chicago, IL.
Kidney transplantation is the most successful treatment for end stage renal disease; however not all comorbidities of the disease are addressed by surgery. Depression and…
2018 American Transplant Congress
Transplantation of Very Small Pediatric En Bloc Renal Allografts from Donors Less Than 8 Months of Age Have Similar Outcomes to Donors More Than 8 Months
S. Aquil,^1,2,3 N. Mitrou,^1,3 V. McAlister,^1,2,3 A. Sener,^1,2,3 P. Luke.^1,2,3
¹Departments of Surgery and Transplant, London Health Sciences Centre, University Hospital, London, ON, Canada; ²Microbiology and Immunology and Matthew Mailing Center for Transplant Studies, London Health Sciences Centre, University Hospital, London, ON, Canada; ³Departments of Surgery and Transplant, Western University, London, ON, Canada.
Purpose: Few programs use kidneys from donors with body weight (BW) less than 10 kg or less than 8 months of age, for fear of…
2018 American Transplant Congress
Long-Term Outcome of Pediatric Kidney Transplantation: A Single-Center Experience over the past Three Decades in Japan
Y. Aoki,¹ H. Satoh,¹ Z. Matsui,¹ R. Hamada,² Y. Hamasaki,³ S. Shishido.³
¹Urology and Kidney Transplantation, Tokyo Metropolitan Children's Medical Center, Fuchu-shi, Tokyo, Japan; ²Nephrology, Tokyo Metropolitan Children's Medical Center, Fuchu-shi, Tokyo, Japan; ³Nephrology, Toho University Faculty of Medicine, Ota-ku, Tokyo, Japan.
Purpose: Kidney transplantation (KTx) is the preferred treatment for children with ESRD. Although the steady advances in immunosuppression have enabled control of early acute rejection…
2018 American Transplant Congress
Increasing Obesity Prevalence in the United States Pediatric End-Stage Renal Disease Population
B. Shelton,¹ P. MacLennan,¹ R. Reed,¹ M. Mustian,¹ D. McWilliams,¹ D. Sawinski,² J. Locke.¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL; ²Medicine, University of Pennsylvania, Philadelphia, PA.
Background: Obesity prevalence among children in the United States (US) is high, but the rate of increase has slowed over time. Among pediatric end-stage renal…